Enlivex Therapeutics Ltd.(ENLV)

Biotechnology · Ness Ziona, TA

$0.34-0.02 (-6.02%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Enlivex Therapeutics (ENLV) Price/OCF Ratio: History & Chart | TGMCharts

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T20:11:28.345Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:11:28.345Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 5,726,252
TTM operating cash flow · period ending 2026-06-30: -15,804,857

FMP input reference: 16b0ce149acf027305ec47ed69e441f7c4eae43bc3095c7aeda967d53938ba16

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

ENLV Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

ENLV Competitors' Price/OCF Ratio

ENLV

Enlivex Therapeutics Ltd.

Current

Market Cap

$5.73M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVNO

enVVeno Medical Corporation

vs ENLV

Market Cap

$5.66M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCY

Lucyd, Inc

vs ENLV

Market Cap

$5.80M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs ENLV

Market Cap

$5.82M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs ENLV

Market Cap

$5.63M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNOA

Sonoma Pharmaceuticals, Inc.

vs ENLV

Market Cap

$5.89M

Price/OCF Ratio

N/A

TTM Avg

15.21

3Y Avg

15.21

5Y Avg

15.21

CDIO

Cardio Diagnostics Holdings, Inc.

vs ENLV

Market Cap

$5.93M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCNX

Scienture Holdings, Inc.

vs ENLV

Market Cap

$6.11M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GELS

Gelteq Limited Ordinary Shares

vs ENLV

Market Cap

$5.32M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNGX

Soligenix, Inc.

vs ENLV

Market Cap

$5.31M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Enlivex Therapeutics Ltd. (ENLV)	$5.73M	N/A	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.66M	N/A	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.80M	N/A	N/A	N/A	N/A
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.82M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	N/A	N/A	N/A	N/A
Sonoma Pharmaceuticals, Inc. (SNOA)vs ›	$5.89M	N/A	15.21	15.21	15.21
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$5.93M	N/A	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$6.11M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.32M	N/A	N/A	N/A	N/A
Soligenix, Inc. (SNGX)vs ›	$5.31M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

ENLV Price/OCF Ratio Metrics

ENLV Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics